One of San Antonio’s largest employers, USAA, is suing another massive banker of its use of mobile check cashing software – an invention for which the military financier has held several patents since ...

Resident Evil cemented itself as a successful video game adaptation film franchise long before properties like Sonic the Hedgehog, The Super Mario Bros., and more came into the picture. Loosely ...

The Arkansas Lottery offers several draw games for those aiming to win big. Here’s a look at Thursday, March 20, 2025 results for each game: Midday: 1-1-4 Evening: 7-6-3 Check Cash 3 payouts and ...

The Boston Celtics have officially changed hands, with a record-breaking sale price of $6.1 billion that has caught the attention of sports fans and analysts alike. This monumental transaction, ...

Indian Premier League (IPL) team owners are tactically growing their footprint in the cricket world by buying interests in clubs from other international T20 leagues. These include some of the ...

Management maintained its projection of $400 million in peak US sales for its sarcoma franchise, driven by TECELRA and Lete-cel. The company expects TECELRA's sales to accelerate quarterly in 2025.

A Minneapolis woman is accused of attempting to cash a fraudulent check in St. Peter and leading law enforcement on a car chase.

Shubman Gill will lead Gujarat Titans in IPL 2025. Torrent Group has formally completed the long-awaited takeover of Gujarat Titans (GT) weeks before the start of the Indian Premier League (IPL) 2025 ...

The San Francisco Giants have sold a stake in the franchise to a private equity group, the team announced Tuesday. Sixth Street has purchased about 10 percent of the Giants with the team aiming to ...

Making a big splash in free agency isn’t necessarily the best recipe for success. On Sunday, NFL podcast host Colin Cowherd talked about how some teams today continue to be successful despite ...

Cytokinetics is now rapidly moving into commercialization efforts with Aficamten. If all goes well, it could be approved by September 2025. Aficamten had favorable Phase 3 data, so it could have ...